Back to Results
First PageMeta Content
Chemistry / Pharmacology / Clinical research / Nicotinic agonists / Bioethics / Varenicline / Bupropion / Nicotine patch / Chronic obstructive pulmonary disease / Medicine / Smoking cessation / Ethics


Document Date: 2014-10-01 21:56:23

Open Document

File Size: 84,89 KB

Share Result on Facebook

City

San Diego / /

Company

Pfizer Australia Pty Ltd / /

Country

Australia / Turkey / /

Currency

USD / /

Event

FDA Phase / /

Facility

American College of Cardiology / American College of Chest Physicians Annual Meeting / /

IndustryTerm

usual healthcare / non-treatment extension protocol / /

MedicalCondition

myocardial infarction / cerebrovascular accidents / hypertension / COPD / Moderate COPD / cardiac disease / depression / Cardiovascular Disease / /

MedicalTreatment

counselling / nicotine replacement therapy / retreatment / /

Organization

the American College / American College of Chest Physicians Annual / Medical Association / American Medical Association / /

Position

Trial ID/First Protocol title/ Publication title Author / representative / Governor / /

Product

bupropion hydrochloride / Varenicline / beta-2 / nicotine / A3051018 / A3051028 / /

PublishedMedium

Critical Care Medicine / Journal of the American Medical Association / /

Region

Latin America / /

Technology

alpha / non-treatment extension protocol / /

URL

http /

SocialTag